Researchers in Hong Kong find ulcer drug could be effective in halting coronavirus replication

About This Source - South China Morning Post

The South China Morning Post (SCMP), with its Sunday edition, the Sunday Morning Post, is a Hong Kong-based English-language newspaper founded in 1903. It is Hong Kong’s newspaper of record, owned by Alibaba Group.

Recent from South China Morning Post:

  • Millions of new blue-collar jobs are piling on pressure for many workers in China
  • Hong Kong’s camera guardian: why David Chan has spent 60 years collecting vintage photography gear
  • India’s Durga Puja festival kicks off amid coronavirus restrictions
  • South China Morning Post published this video item, entitled “Researchers in Hong Kong find ulcer drug could be effective in halting coronavirus replication” – below is their description.

    A University of Hong Kong study has found that ranitidine bismuth citrate, or RBC, a drug commonly used to treat stomach ulcers, shows promise in preventing the SARS-CoV-2 coronavirus from replicating in an animal model. The researchers said RBC’s effectiveness is comparable to the outcome of the coronavirus drug remdesivir, but at a much lower cost. Support us: https://subscribe.scmp.com

    South China Morning Post YouTube Channel

    Got a comment? Leave your thoughts in the comments section, below. Please note comments are moderated before publication.

    Leave a Comment